Ibogaine Induces Cardiotoxic Necrosis in Rats-The Role of Redox Processes

Area of Science:

• Pharmacology
• Toxicology
• Cardiovascular Research

Background:

• Ibogaine, an indole alkaloid, is used for addiction treatment.
• Adverse effects, including fatal complications, are linked to ibogaine-induced cardiac arrhythmias.
• Higher bioavailability of ibogaine and noribogaine in female rats suggests potential sex-based differences in toxicity.

Purpose of the Study:

• To investigate the cardiotoxic effects of ibogaine in a rat model.
• To determine if ibogaine induces cardiac histopathology and alters oxidative/antioxidant balance.
• To explore potential sex-based differences in ibogaine cardiotoxicity.

Main Methods:

• Rats were administered a single oral dose of ibogaine (1 or 20 mg/kg).
• Cardiac histopathology was assessed at 6 and 24 hours post-administration.
• Oxidative and antioxidant balance markers were analyzed.

Main Results:

• Ibogaine induced dose-dependent cardiotoxic necrosis.
• Necrosis was observed at 6 and 24 hours and was not inflammatory.
• No consistent dose- or time-dependent changes in oxidative/antioxidant balance were found.

Conclusions:

• Ibogaine administration causes dose-dependent cardiac necrosis in rats.
• The study did not establish a role for redox processes or oxidative stress in ibogaine-induced cardiotoxicity.
• Findings contribute to understanding ibogaine cardiotoxicity, a major risk factor in human use.